NBIX icon

Neurocrine Biosciences

117 hedge funds and large institutions have $547M invested in Neurocrine Biosciences in 2013 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 34 increasing their positions, 43 reducing their positions, and 27 closing their positions.

Holders
117
Holders Change
-5
Holders Change %
-4.1%
% of All Funds
3.4%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.03%
New
22
Increased
34
Reduced
43
Closed
27
Calls
$6.31M
Puts
$1.11M
Net Calls
+$5.2M
Net Calls Change
-$26K
Name Holding Trade Value Shares
Change
Shares
Change %
DCM
126
Driehaus Capital Management
Illinois
-$892K -78,764 Closed
UOC
127
UBS O'Connor
Illinois
-$837K -73,900 Closed
American Century Companies
128
American Century Companies
Missouri
-$705K -62,278 Closed
HVC
129
Healthcare Value Capital
New Jersey
-$566K -50,000 Closed
Schroder Investment Management Group
130
Schroder Investment Management Group
United Kingdom
-$504K -44,507 Closed
Tudor Investment Corp
131
Tudor Investment Corp
Connecticut
-$350K -30,900 Closed
FM
132
Forward Management
California
-$283K -25,000 Closed
TAM
133
Tocqueville Asset Management
New York
-$264K -23,350 Closed
Principal Financial Group
134
Principal Financial Group
Iowa
-$241K -21,277 Closed
LPL Financial
135
LPL Financial
California
-$202K -19,699 Closed
WB
136
WesBanco Bank
West Virginia
-$181K -16,000 Closed
SG Americas Securities
137
SG Americas Securities
New York
-$151K -13,310 Closed
Jane Street
138
Jane Street
New York
-$127K -11,177 Closed
RFC
139
Russell Frank Company
Washington
-$93K -8,230 Closed
TRCT
140
Tower Research Capital (TRC)
New York
-$51K -4,478 Closed
HIM
141
Hillsdale Investment Management
Ontario, Canada
-$44K -3,900 Closed
SCA
142
SAC Capital Advisors
Connecticut
-$44K -3,900 Closed
FAM
143
Fred Alger Management
New York
-$17K -1,521 Closed
PCM
144
Prelude Capital Management
New York
-$17K -1,500 Closed